scholarly article | Q13442814 |
P2093 | author name string | Y Xu | |
F Liu | |||
S E Benashski | |||
L D McCullough | |||
M Siegel | |||
P2860 | cites work | Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q22306347 |
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ | Q24329243 | ||
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial | Q28196294 | ||
Menopause and stroke and the effects of hormonal therapy | Q28221875 | ||
Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection | Q28305682 | ||
NeuN, a neuronal specific nuclear protein in vertebrates | Q28510657 | ||
Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: a qualitative and quantitative study | Q28570697 | ||
Sexually dimorphic expression of estrogen receptor beta in the anteroventral periventricular nucleus of the rat preoptic area: implication in luteinizing hormone surge | Q28583065 | ||
Long-term ovarian hormone deprivation alters the ability of subsequent oestradiol replacement to regulate choline acetyltransferase protein levels in the hippocampus and prefrontal cortex of middle-aged rats | Q33341460 | ||
Epigenetic regulation of estrogen receptor alpha gene expression in the mouse cortex during early postnatal development | Q33634343 | ||
The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1. | Q33921182 | ||
NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer | Q33979905 | ||
Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury | Q34114102 | ||
The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia | Q34335614 | ||
Estrogen replacement therapy, atherosclerosis, and vascular function | Q34541886 | ||
The role of DNA methylation in the central nervous system and neuropsychiatric disorders | Q34613653 | ||
Gender dimorphism in immune responses following trauma and hemorrhage | Q34981878 | ||
Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor | Q34985015 | ||
Sex differences in age trajectories of physiological dysregulation: inflammation, metabolic syndrome, and allostatic load | Q35021143 | ||
Ischemic tolerance and endogenous neuroprotection | Q35126696 | ||
Estrogen and ischemic neuroprotection: an integrated view | Q35162545 | ||
Cellular targets of brain inflammation in stroke. | Q35165941 | ||
Age-related changes in AMP-activated protein kinase after stroke | Q35678172 | ||
Rise and fall of hormone therapy in postmenopausal women with cardiovascular disease | Q35691413 | ||
Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. | Q35749627 | ||
Transcription factor cross-talk: the estrogen receptor and NF-kappaB. | Q36056036 | ||
Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's health initiative | Q36106199 | ||
Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group | Q36542530 | ||
The inflammatory response in stroke | Q36692346 | ||
The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? | Q36704008 | ||
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial | Q36851595 | ||
MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia | Q36859370 | ||
The complex role of estrogens in inflammation. | Q36886660 | ||
Neuroprotective effects of estrogens following ischemic stroke. | Q36901553 | ||
Sex differences in caspase activation after stroke | Q37172671 | ||
TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion | Q37173457 | ||
NF‐κB and innate immunity in ischemic stroke | Q37252167 | ||
Changes in experimental stroke outcome across the life span | Q37356917 | ||
Sexually dimorphic expression of hypothalamic estrogen receptors α and β and Kiss1 in neonatal male and female rats | Q37417457 | ||
Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender | Q39128180 | ||
The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells | Q40127265 | ||
Acute ischemic stroke and transient ischemic attack in the very old--risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years | Q40188824 | ||
Somatostatin receptor 2 is activated in cortical neurons and contributes to neurodegeneration after focal ischemia. | Q40480325 | ||
17beta-estradiol is a hormonal regulator of mirex tumor promotion sensitivity in mice | Q40705902 | ||
Neuroprotective effects of estradiol in middle-aged female rats | Q43516260 | ||
Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. | Q43600083 | ||
A clinical trial of estrogen-replacement therapy after ischemic stroke | Q43779426 | ||
Estrogen and aging affect the subcellular distribution of estrogen receptor-alpha in the hippocampus of female rats. | Q43972751 | ||
Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium | Q44265520 | ||
Differential contributions of ovarian and extraovarian factors to age-related reductions in plasma estradiol and progesterone during the estrous cycle of C57BL/6J mice | Q44647175 | ||
Characterization of the neuronal marker NeuN as a multiply phosphorylated antigen with discrete subcellular localization. | Q45191282 | ||
A semiautomated method for measuring brain infarct volume. | Q45954002 | ||
Lack of vasoactive intestinal peptide reduces testosterone levels and reproductive aging in mouse testis | Q46054668 | ||
Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta | Q46483528 | ||
Sex differences in management and outcome after stroke: a Swedish national perspective | Q47766339 | ||
Effect of age in rodent models of focal and forebrain ischemia | Q48936976 | ||
Aging has a complex effect on a rat model of ischemic stroke. | Q51338278 | ||
Endogenous estrogens, through estrogen receptor α, constrain autoimmune inflammation in female mice by limiting CD4+ T-cell homing into the CNS. | Q51531286 | ||
The dynamics of X-inactivation skewing as women age. | Q53901083 | ||
Neurochemical changes in the aging process: implications in medication in the elderly. | Q54986690 | ||
Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection | Q60542576 | ||
Neuroprotective Effect of Nitroglycerin in a Rodent Model of Ischemic Stroke: Evaluation of Bcl‐2 Expression | Q61896999 | ||
Effects of estradiol and progesterone on plasma gonadotropins, prolactin, and LHRH in specific brain areas of ovariectomized rats | Q70158859 | ||
Age-dependent increase in infarct volume following photochemically induced cerebral infarction: putative role of astroglia | Q73744988 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 2 | |
P921 | main subject | estrogen | Q277954 |
P304 | page(s) | 319-330 | |
P577 | publication date | 2012-02-01 | |
P1433 | published in | Journal of Neuroendocrinology | Q3186929 |
P1476 | title | Effects of chronic and acute oestrogen replacement therapy in aged animals after experimental stroke | |
P478 | volume | 24 |
Q28393376 | Differential effects of aging and sex on stroke induced inflammation across the lifespan |
Q47951718 | Effect of estrogen administration on middle cerebral arterial viscoelastic properties in aged female rats |
Q47576042 | Effects of Female Sex Steroids Administration on Pathophysiologic Mechanisms in Traumatic Brain Injury |
Q89110504 | Estrogen, migraine, and vascular risk |
Q38739583 | Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury |
Q26866359 | Interactions between age, sex, and hormones in experimental ischemic stroke |
Q57178108 | Ischemic stroke across sexes: What is the status quo? |
Q34768423 | Knockout of vascular early response gene worsens chronic stroke outcomes in neonatal mice |
Q27001603 | Mechanism of the sex difference in endothelial dysfunction after stroke |
Q36579398 | Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis |
Q38916635 | Microglia and Monocyte-Derived Macrophages in Stroke |
Q90077286 | Molecular mechanisms and cellular events involved in the neuroprotective actions of estradiol. Analysis of sex differences |
Q36741774 | Neonatal testosterone exposure protects adult male rats from stroke |
Q39038954 | PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. |
Q35072419 | Perfusion of ischemic brain in young and aged animals: a laser speckle flowmetry study |
Q37567253 | Sex differences in neuroinflammation and neuroprotection in ischemic stroke. |
Q57168766 | Sex differences in stroke: Challenges and opportunities |
Q27022768 | Sex differences in stroke: the contribution of coagulation |
Q36185871 | Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke |
Q34969971 | Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice. |
Q37194231 | Stroke sensitivity in the aged: sex chromosome complement vs. gonadal hormones |
Q35140252 | Sustained reprogramming of the estrogen response after chronic exposure to endocrine disruptors |
Q89276299 | Systemic Estrone Production and Injury-Induced Sex Hormone Steroidogenesis after Severe Traumatic Brain Injury: A Prognostic Indicator of Traumatic Brain Injury-Related Mortality |
Q42085888 | The Importance of Considering Sex Differences in Translational Stroke Research |
Q28384880 | The effects of estrogen in ischemic stroke |
Q47877619 | What Do Experimental Models Teach Us About Comorbidities in Stroke? |
Q58197483 | Withdrawn: Ischemic stroke across sexes: What is the status quo? |
Search more.